646 related articles for article (PubMed ID: 23216382)
1. Long-term administration of rifaximin improves the prognosis of patients with decompensated alcoholic cirrhosis.
Vlachogiannakos J; Viazis N; Vasianopoulou P; Vafiadis I; Karamanolis DG; Ladas SD
J Gastroenterol Hepatol; 2013 Mar; 28(3):450-5. PubMed ID: 23216382
[TBL] [Abstract][Full Text] [Related]
2. [The effect of portal hypertension on prognosis in patients with decompensated liver cirrhosis].
Zhang JY; Kuai JH; Jia JD; Wang BE; Qin CY
Zhonghua Gan Zang Bing Za Zhi; 2009 Apr; 17(4):263-5. PubMed ID: 19403023
[TBL] [Abstract][Full Text] [Related]
3. Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis.
Abraldes JG; Tarantino I; Turnes J; Garcia-Pagan JC; Rodés J; Bosch J
Hepatology; 2003 Apr; 37(4):902-8. PubMed ID: 12668985
[TBL] [Abstract][Full Text] [Related]
4. Rifaximin treatment is associated with reduced risk of cirrhotic complications and prolonged overall survival in patients experiencing hepatic encephalopathy.
Kang SH; Lee YB; Lee JH; Nam JY; Chang Y; Cho H; Yoo JJ; Cho YY; Cho EJ; Yu SJ; Kim MY; Kim YJ; Baik SK; Yoon JH
Aliment Pharmacol Ther; 2017 Nov; 46(9):845-855. PubMed ID: 28836723
[TBL] [Abstract][Full Text] [Related]
5. Low-dose rifaximin prevents complications and improves survival in patients with decompensated liver cirrhosis.
Zeng X; Sheng X; Wang PQ; Xin HG; Guo YB; Lin Y; Zhong JW; He CZ; Yin J; Liu TT; Ma WJ; Xiao X; Shi PM; Yuan ZL; Yang L; Ma X; Xu JM; Shen XZ; Yang CQ; Zhu X; Lv NH; Xie WF
Hepatol Int; 2021 Feb; 15(1):155-165. PubMed ID: 33385299
[TBL] [Abstract][Full Text] [Related]
6. Rifaximin has no effect on hemodynamics in decompensated cirrhosis: A randomized, double-blind, placebo-controlled trial.
Kimer N; Pedersen JS; Busk TM; Gluud LL; Hobolth L; Krag A; Møller S; Bendtsen F;
Hepatology; 2017 Feb; 65(2):592-603. PubMed ID: 27775818
[TBL] [Abstract][Full Text] [Related]
7. Review article: potential mechanisms of action of rifaximin in the management of hepatic encephalopathy and other complications of cirrhosis.
Bajaj JS
Aliment Pharmacol Ther; 2016 Jan; 43 Suppl 1():11-26. PubMed ID: 26618922
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological reduction of portal pressure and long-term risk of first variceal bleeding in patients with cirrhosis.
Turnes J; Garcia-Pagan JC; Abraldes JG; Hernandez-Guerra M; Dell'Era A; Bosch J
Am J Gastroenterol; 2006 Mar; 101(3):506-12. PubMed ID: 16542287
[TBL] [Abstract][Full Text] [Related]
9. Presentation and complications associated with cirrhosis of the liver.
Poordad FF
Curr Med Res Opin; 2015 May; 31(5):925-37. PubMed ID: 25697811
[TBL] [Abstract][Full Text] [Related]
10. Three decades of experience with emergency portacaval shunt for acutely bleeding esophageal varices in 400 unselected patients with cirrhosis of the liver.
Orloff MJ; Orloff MS; Orloff SL; Rambotti M; Girard B
J Am Coll Surg; 1995 Mar; 180(3):257-72. PubMed ID: 7874335
[TBL] [Abstract][Full Text] [Related]
11. [Complications of liver cirrhosis].
Appenrodt B; Trebicka J; Sauerbruch T
Dtsch Med Wochenschr; 2011 Aug; 136(31-32):1601-4. PubMed ID: 21809252
[No Abstract] [Full Text] [Related]
12. The Use of Rifaximin in Patients With Cirrhosis.
Caraceni P; Vargas V; Solà E; Alessandria C; de Wit K; Trebicka J; Angeli P; Mookerjee RP; Durand F; Pose E; Krag A; Bajaj JS; Beuers U; Ginès P;
Hepatology; 2021 Sep; 74(3):1660-1673. PubMed ID: 33421158
[TBL] [Abstract][Full Text] [Related]
13. Maintenance of hemodynamic response to treatment for portal hypertension and influence on complications of cirrhosis.
Villanueva C; López-Balaguer JM; Aracil C; Kolle L; González B; Miñana J; Soriano G; Guarner C; Balanzó J
J Hepatol; 2004 May; 40(5):757-65. PubMed ID: 15094222
[TBL] [Abstract][Full Text] [Related]
14. Current status of liver diseases in Korea: liver cirrhosis.
Jang JW
Korean J Hepatol; 2009 Dec; 15 Suppl 6():S40-9. PubMed ID: 20037279
[TBL] [Abstract][Full Text] [Related]
15. Emricasan to prevent new decompensation in patients with NASH-related decompensated cirrhosis.
Frenette C; Kayali Z; Mena E; Mantry PS; Lucas KJ; Neff G; Rodriguez M; Thuluvath PJ; Weinberg E; Bhandari BR; Robinson J; Wedick N; Chan JL; Hagerty DT; Kowdley KV;
J Hepatol; 2021 Feb; 74(2):274-282. PubMed ID: 33038432
[TBL] [Abstract][Full Text] [Related]
16. Primary Prophylaxis to Prevent the Development of Hepatic Encephalopathy in Cirrhotic Patients with Acute Variceal Bleeding.
Higuera-de-la-Tijera F; Servín-Caamaño AI; Salas-Gordillo F; Pérez-Hernández JL; Abdo-Francis JM; Camacho-Aguilera J; Alla SN; Jiménez-Ponce F
Can J Gastroenterol Hepatol; 2018; 2018():3015891. PubMed ID: 30079329
[TBL] [Abstract][Full Text] [Related]
17. [Managing the complications of cirrhosis].
Deltenre P; Mathurin P; Barraud H; Bronowicki JP; Jacquet E; Puche P; Jaber S; Navarro F; Pageaux GP
Rev Prat; 2005 Sep; 55(14):1555-63. PubMed ID: 16255297
[TBL] [Abstract][Full Text] [Related]
18. Current and future pharmacological therapies for managing cirrhosis and its complications.
Kockerling D; Nathwani R; Forlano R; Manousou P; Mullish BH; Dhar A
World J Gastroenterol; 2019 Feb; 25(8):888-908. PubMed ID: 30833797
[TBL] [Abstract][Full Text] [Related]
19. Clinical course of alcoholic liver cirrhosis: a Danish population-based cohort study.
Jepsen P; Ott P; Andersen PK; Sørensen HT; Vilstrup H
Hepatology; 2010 May; 51(5):1675-82. PubMed ID: 20186844
[TBL] [Abstract][Full Text] [Related]
20. Acute Liver Injury and Decompensated Cirrhosis.
Crismale JF; Friedman SL
Med Clin North Am; 2020 Jul; 104(4):647-662. PubMed ID: 32505258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
